cakirinsights.com Viking Therapeutics Rejecting This Price Level

Viking Therapeutics Rejecting This Price Level

Viking Therapeutics Rejecting This Price Level

Before testing the $30 region, Viking is likely to retest the descending trendline around $34. This move could represent a 10% gain in the short term.

If the descending trendline breaks, the next potential target would be $44, signaling a strong bullish continuation. Keep an eye on price action and volume confirmation! 📈🔥





Disclaimer
The information and publications on CakirInsights.com do not constitute and should not be considered as financial, investment, trading, or any other form of advice or recommendation. All analyses and insights are provided for informational and educational purposes only. Please read our Terms of Use for more details.

Leave a Comment

Your email address will not be published. Required fields are marked *